Medicines Co. (MDCO) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Provision for income taxes: -163K
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Provision for income taxes: -163K
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($0.82), $0.06 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $72.7 million versus the consensus estimate of $68.58 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Sempra Energy (SRE) Tops Q3 EPS by 20c ; Offers Guidance
- Tecnoglass (TGLS) Tops Q3 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
